Monitoring Advanced Chronic Liver Disease Risk

Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease

Recruiting Observational Study
Liver Diseases Hepatocellular Carcinoma Hepatocarcinoma Advanced Chronic Liver Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
600 (estimated)
Sponsor
University Hospital Muenster · Other
Who this trial is looking for

This trial is looking for patients with advanced chronic liver disease. Participants will be monitored to see how their condition develops and will receive appointments based on their level of risk.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have advanced chronic liver disease.

You may not be able to join if

  • I am pregnant.
  • I am under 18 years old.
  • I have current cancer, except for non-melanocytic skin cancer.
  • I have severe extra-hepatic diseases.
  • I am HIV positive.
  • I have had a liver or other organ transplant.
  • I cannot provide consent.
  • My doctor does not think I can follow the study protocol.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The aim of this observational study is to predict the short- and long-term development of acute severe disease events, de novo hepatocarcinoma (HCC) and mortality in patients with advanced chronic liver disease using the M10S20 (Liver stiffness and Model for End-Stage Liver Disease Score \[MELD\] combined) and PLEASE (Platelet, Etiology, Age, Sex und Elastography) scores, as well as the validation…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * The patient admitted/referred to study center is hospitalized or is an outpatient with advanced chronic liver disease (based on the BAVENO criteria) Exclusion Criteria: * Pregnancy * Age \<18 * Evidence of current malignancy except for non-melanocytic skin cancer * Presence …
Contacts

Jonel Trebicka, Prof. Dr. med.

+49 02518359689

jonel.trebicka@ukmuenster.de

CONTACT

Josune Cabello Calleja, PhD

+34 688689194

josune.cabello@ukmuenster.de

CONTACT